Interleukin Genetics and Pittsburgh Business Group on Health Forge Relationship to Bring the ILUSTRA™ Inflammation Management Program to Pittsburgh Area Employers
February 15, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
Interleukin Genetics Reports Third Quarter 2016 Financial Results
November 15, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its fiscal third quarter of 2016, ended September 30, 2016, and...
Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2016 Financial Results
November 09, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Tuesday, November 15, 2016, at 8:30 a.m....
Interleukin Genetics Launches The ILUSTRA™ Inflammation Management Program
November 03, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics of chronic inflammation, today unveiled the ILUSTRA™...
Interleukin Genetics Cites Role in Key Antisense Drug Trial Published in The Lancet
September 22, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life science company focused on the genetics of chronic inflammation, today announced their contribution...
Interleukin-1 Genetic Variations Influence Obesity Effect in Periodontal Disease Progression
August 23, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 23, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics of chronic inflammation, today announced the publication of...
Interleukin Genetics Reports Second Quarter 2016 Financial Results
August 16, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its fiscal second quarter of 2016, ended June 30, 2016, and provided a...
Interleukin Genetics Announces Conference Call to Discuss Second Quarter 2016 Financial Results
August 09, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Tuesday, August 16, 2016, at 8:30 a.m....
Interleukin Genetics Strengthens Commercial Leadership with Key Appointments
August 03, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life science company focused on the genetics of chronic inflammation, today announced the appointment of...
Interleukin Genetics, Inc. Announces $5.6 Million Private Placement Financing
August 01, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic diseases...